Epidermal growth factor receptor inhibition by erlotinib prevents vascular smooth muscle cell and monocyte-macrophage function in vitro

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalTransplant Immunology
Volume32
Issue number3
Pages (from-to)175-178
Number of pages4
ISSN0966-3274
DOIs
Publication statusPublished - Jun 2015
MoE publication typeA1 Journal article-refereed

Fields of Science

  • EGFR
  • Erlotinib
  • Smooth muscle cell
  • Monocyte
  • Macrophage
  • Chronic allograft injury
  • CHRONIC ALLOGRAFT NEPHROPATHY
  • ANGIOTENSIN-II
  • EGF-RECEPTOR
  • TRANSACTIVATION
  • PROLIFERATION
  • ALDOSTERONE
  • ACTIVATION
  • INJURY
  • ATHEROSCLEROSIS
  • DIFFERENTIATION
  • 3126 Surgery, anesthesiology, intensive care, radiology

Cite this